Dry body weight: Water and sodium removal targets in PD

Contributions to Nephrology

Volumn 150, Issue , 2006, Pages 104-110

  Krediet, Raymond T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; SODIUM;

BODY WATER; BODY WEIGHT; HUMAN; IMPEDANCE; METABOLISM; PERITONEAL DIALYSIS; REVIEW;

BODY WATER; BODY WEIGHT; DIURETICS; ELECTRIC IMPEDANCE; HUMANS; PERITONEAL DIALYSIS; SODIUM;

EID: 33745226682     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000093509     Document Type: Review

References (30)

1. Levey AS, Beto JA, Coronado BE, et al: Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 1998;32:853-905.
2. Van der Sande FM, Levin NW, Koomen JP, Hoenick NA, Leunissen KML: Intradialystic complications: pathophysiology, prevention and treatments; in Hörl WH, Kock KM, Lindasy RM, Ronco C, Winschester JF (eds): Replacement of Renal Function by Dialysis, ed 5. Dordrecht, Kluwer Academic Publishers 2004, pp 1105-1127.
3. Cocchi R, Esposti ED, Fabhri A, et al: Prevalence of hypertension in patients on peritoneal dialysis: results of an Italien multicenter study. Nephrol Dial Transplant 1999;14:1536-1540.
4. Lameire N, Vanholder RC, Van Loo A, et al: Cardiovascular diseases in peritoneal dialysis patients: the size of the problem. Kidney Int 1996;50(suppl 56):S28-S36.
5. Enia G, Mallamaci F, Benedetto FA, et al: Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than hemodialysis patients. Nephrol Dial Transplant 2001;16:1459-1464.
6. Jager KJ, Merkus MP, Dekker FW, et al: Mortality and technique failure in patients starting chronic peritoneal dialysis: results of the Netherlands cooperative study on the adequacy of dialysis. Kidney Int 1999;55:1476-1485.
7. Kouw PM, Kooman JP, Cheriex EC, Olthof CG, de Vries PM, Leunissen KM: Assessment of postdialysis dry weight: a comparison of techniques. J Am Soc Nephrol 1993;4:98-104.
8. van de Kerkhof J, Hermans M, Beerenhout C, Konings C, van der Sande FM, Kooman JP: Reference values for multifrequency bioimpedance analysis in dialysis patients. Blood Purif 2004;22:301-306.
9. Struijk DG, Krediet RT, Koomen GCM, Boeschoten EW, Arisz L: The effect of serum albumin at the start of continious ambulatory peritoneal dialysis treatment on patient survival. Perit Dial Int 1994;14:121-126.
10. Jones CH, Smye SW, Newstead CG, Will EJ, Davison AM: Extracellular fluid volume determined by bioelectric impedance and serum albumin in CAPD patients. Nephrol Dial Transplant 1998;13:393-397.
11. Wolfram G, Sitter T, Grottsman M, Gereer R, Schiff H: Assessment of dry weight in haemodialysis patients by the volume markers ANP and cGMP. Nephrol Dial Transplant 1996;11(suppl 2):528-530.
12. Nakao K, Ogawa Y, Suga S, Imura H: Molecular biology and biochemistry of the natriuretic peptide system. I. natriuretic peptides. J Hypertension 1992;10:907-912.
13. Matthie J, Zarowtiz B, De Lorenzo A, et al: Analytic assessment of the various bioimpedance nethods used to estimate body water. Appl Physiol 1998;84:1801-1816.
14. Katzarski K, Charra B, Laurent G, et al: Multifrequency bioimpedance in assessment of dry water in haemodialysis. Nephrol Dial Transplant 1996;11(suppl 2):S20-S23.
15. Konings CJAM, Kooman JP, Schonk M, et al: Assessment of fluid state in peritoneal dialysis patients. Perit Dial Int 2002;22:683-692.
16. Van Olden RW, Guchelaar H-J, Struijk DG, Krediet RT, Arisz L: Acute effects of high-dose furosemide on residual renal function in CAPD patients. Perit Dial Int 2003;23:339-347.
17. Bargman JM, Thorpe KE, Churchill DN, The CANUSA Peritoneal Dialysis Study Group: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001;12:2158-2162.
18. Termorshuizen F, Korevaar JC, Dekker FW, van Maanen JG, Boeschoten EW, Krediet RT, The NECOSAD Study Group: The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands cooperative study on the adequacy of dialysis (NECOSAD)-2. Am J kidney Dis 2003;41:1293-1302.
19. Ates K, Nergizoglu G, Keven K, et al: Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001;60:767-776.
20. Jansen MAM, Termorshuizen F, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT, The NECOSAD Study Group. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 2005;68:1199-1205.
21. Brown EA, Davies SJ, Ruttersford P, et al: Survival of functionally anuric patients on automated peritoneal dialysis. The EUROPEAN APD Outcome Study. J Am Soc Nephrol 2003;14: 2948-1205.
22. Rodriguez EA, Carmona A, Fontan MF: Sodium removal in patients undergoing CAPD and auto-mated peritoneal dialysis. Perit Dial Int 2002;22:705-713.
23. Nolph KD, Sorkin MI, Moore H: Autoregulation of sodium and potassium removal during continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 1980;26:334-338.
24. Wang T, Waniewski J, Heimbürger O, Werynski A, Lindholm B: A quantitative analysis of sodium transport and removal during peritoneal dialysis. Kidney Int 1997;52:1609-1616.
25. Fine A, Foataine B, Madge MA: Commonly prescribed salt intake in continuous ambulatory peritoneal dialysis patients is too restrictive: results of a double-blind crossover study. J Am Soc Nephrol 1997;8:1311-1314.
26. Imholz ALT, Koomen GCM, Struijk DG, Arisz L, Krediet RT: Fluid and solute transport in CAPD patients using ultralow sodium dialysate. Kidney Int 1994;46:333-340.
27. Nakayama M, Yokoyama K, Kubo H, et al: The effect of ultra-low sodium dialysate in CAPD. A kinetic and clinical analysis. Clin Nephrol 1996;45:188-193.
28. Struijk DG, Krediet RT: Sodium balance in automated peritoneal dialysis. Perit Dial Int 2000;20 (suppl 2):S101-S105.
29. Günal AI, Duman S, Özkakya M, et al: Strict volume control normalizes hypertension in peri-toneal dialysis patients. Am J Kidney Dis 2001;37:588-593.
30. Davies SJ, Phillips L, Naish PF, Russel GI: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. JAm Soc Nephrol 2001;12:1046-1051.